The Mexican Government has paid $ 159.8 million as an advance for more than 51 million doses of the vaccine of the Covid-19 of Covax, the platform of the World Health Organization (WHO), as reported this Saturday by the Ministry of Foreign Affairs (SRE).
The Ministry of Finance and Public Credit (SHCP) “fulfilled the commitments” by make the transfer on Thursday and deliver the risk guarantee documents for more than $ 20.6 millionsaid the Foreign Ministry in a statement.
“With this payment, Mexicoguarantees to have options to acquire doses of a successful vaccine against Covid-19 within Covax’s portfolio, “said the SRE.
Mexico formally entered Covax in September, an instrument of the Accelerator for Access to Tools against Covid-19 (ACTA), promoted by the WHO, to ensure equitable access to vaccines against Covid-19.
The agreement “guarantees Mexico the acquisition of sufficient doses for immunize up to 20% of your population that, in a vaccination regimen of two doses per patient, they represent 51 million 573,200 doses, “said the SRE this Saturday.
The Government of Mexico has prioritized early access to the vaccine as a strategy against the coronavirus pandemic, which has left more than 83,600 deaths and 814,328 infections in the country.
In addition to Covax, Mexico and Argentina announced a agreement in august for produce the vaccine for Latin America developed by the University of Oxford and AstraZeneca once it passes phase 3 of the clinical trial in November.
The president, Andrés Manuel López Obrador, has promised that he could start a vaccination campaign in the first quarter of next year. However, before some breaks in clinical trial At AstraZeneca, federal officials have argued that Mexico has its options open.
Mexico has welcomed international laboratories who intend or have started phase 3 of their vaccines in the country, such as Janssen and Novavax from the United States, Sputnik-V from Russia, CureVac from Germany, Cansino from China, Sanofi-Pasteur from France, and ReiThera from Italy.
With this payment to Covax, Mexico seeks purchase options to acquire candidate vaccine doses from the Covax portfolio that are successful, the SRE indicated. “The modality of optional purchase contract subscribed by Mexico allows you choose the vaccine you want to buy, according to your preferences and subject to availability. The Covax Facility has a portfolio of nine candidate vaccines that it will make available, “the statement concluded.